Biomed Central Ltd

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Shoushtari
    Shoushtari
  5. Abou-Alfa
    Abou-Alfa
  6. Cheung
    Cheung
  7. Rudin
    Rudin
  8. Morris
    Morris
  9. Panageas
    Panageas
  10. Schoenfeld
    Schoenfeld

Groups

  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (74)
  3. GSK Faculty (32)
  4. Hematologic Malignancies, Division of (27)
  5. Sloan Kettering Institute Postdocs (27)
  6. Hematology-Oncology Fellows (22)
  7. Melanoma and Immunotherapeutics Service (22)
  8. Weinberg Fellows (18)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (15)
  10. Population Sciences Research Program (15)
Search Within
  1. "2022"
Formats
  1. Journal Article (56)
  2. Meeting Abstract (50)
  3. Review (12)
  4. Guidelines (2)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (82)
  2. Solid Tumor Oncology Division (74)
  3. GSK Faculty (32)
  4. Hematologic Malignancies, Division of (27)
  5. Sloan Kettering Institute Postdocs (27)
  6. Hematology-Oncology Fellows (22)

More Groups

People
  1. Jedd Wolchok (10)
  2. Taha Merghoub (7)
  3. Michael Postow (6)
  4. Robert Motzer (6)
  5. Alexander Shoushtari (5)
  6. Sandra D'Angelo (5)

More People

Years
  1. 2022 (122)
Publications
  1. Journal for ImmunoTherapy of Cancer (75)
  2. BMC Cancer (6)
  3. Journal of Hematology & Oncology (6)
  4. Journal of Translational Medicine (6)
  5. BMC Public Health (3)
  6. Genome Medicine (3)

More Publications

Results (122)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prediction of best response for NSCLC patients receiving immunotherapy by machine learning models
    Meeting Abstract

    Zhang, Y.; Gupta, S.; Belouali, A.; Lev-Ari, S.; Shah, N.; Krishnamurthy, K.; Serzan, M.; Alaoui, A.; McGarvey, P.; Atkins, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Gut dysbiosis suppresses anti-tumor ILC2S in pancreatic cancer
    Meeting Abstract

    Zebboudj, A.; Amisaki, M.; Guasp, P.; Rojas, L.; Sethna, Z.; Theresa, W.; Chandra, A.; Yu, R.; Odgerel, Z.; Soares, K.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • A novel humanized T cell-engaging CD24XCD3 bispecific antibody for CD24-positive solid tumors
    Meeting Abstract

    Espinosa-Cotton, M.; Guo, H. F.; Cheung, N. K.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • A phase I study of personalized adoptive TCR T cell therapy in patients with solid tumors: Safety, efficacy, and T cell trafficking to tumors of non-virally gene edited T cells
    Meeting Abstract

    Foy, S.; Jacoby, K.; Bota, D.; Hunter, T.; Schoenfeld, A.; Pan, Z.; Stawiski, E.; Ma, Y.; Lu, W.; Peng, S. M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Assessing the correlation between CD8 cell PET imaging with 89-ZR-crefmirlimab berdoxam and CD8 cell immunohistochemistry in patients with advanced cancer receiving immunotherapy
    Meeting Abstract

    Postow, M.; Mauguen, A.; Farwell, M.; Gordon, M.; Hays, D.; Wong, J.; Pal, S.; Chen, D.; Ulaner, G.; McConathy, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Provider insights on managing patients on immunotherapy, barriers to clinical trials, and biomarker testing preferences
    Meeting Abstract

    Ackbarali, T.; Neal, J.; Janjigian, Y.; Overman, M.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Comparative safety and effectiveness of IL6R inhibitors, TNF inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
    Meeting Abstract

    Bass, A.; Abdel-Wahab, N.; Sparks, J.; Reid, P.; Calabrese, C.; Jannat-Khah, D.; Rajesh, D.; Ghosh, N.; Mushtak, K.; Al Haj, F.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Uncovering the hidden structure of T cell compositions in peripheral blood after immune checkpoint inhibitor
    Meeting Abstract

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Callahan, M.; Panageas, K.; Shen, R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPĪ±) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • A reproducible pipeline for analysis of multiplex imaging (MIBI) data with application to uncovering novel features of the tumorimmune microenvironment
    Meeting Abstract

    Maxey, J.; Thompson, M.; Campbell, K.; Kamphaus, B.; Bustami, Z.; Santulli-Marotto, S.; Wells, D.; Boffo, S.; Salvador, L.; Scumpia, P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save